Fresenius Kabi starts work on $250m US sterile drug plant

By Gareth Macdonald contact

- Last updated on GMT

Related tags: Manufacturing

Fresenius Kabi execs Steve Nowicki, Dr. Michael Schoenhofen and John Ducker join Mayor Ron Serpico of Melrose Park, Illinois at groundbreaking ceremony
Fresenius Kabi execs Steve Nowicki, Dr. Michael Schoenhofen and John Ducker join Mayor Ron Serpico of Melrose Park, Illinois at groundbreaking ceremony
Fresenius Kabi has started work on a $250m (€220m) sterile drug manufacturing plant in Illinois, US.

The German drug manufacturer announced plans for facility last year​, explaining that construction at the site in Chicago’s Melrose Park suburb will help it capture a greater share of the US injectables market.

The project will create several manufacturing suites equipped with automated aseptic filling lines, expanded lyophilization capabilities, and formulation areas, as well as a dedicated warehouse for raw materials.

Related topics: Processing, Processing equipment, QA/QC

Related news

Show more

Related products

Optimise the texture of pharma gel formulations

Optimise the texture of pharma gel formulations

Stable Micro Systems | 21-Jan-2019 | Technical / White Paper

Convenient, comfortable and highly effective, gel-based pharmaceuticals are booming. For optimal robustness and efficacy, texture is critical. Discover...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...

Steridose

Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers